Hermansen K, Bkdal TA, Dring M, Pietraszek A, Mortensen LS, Jrgensen H, Flint A: Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial
Batty MJ, Chabrier G, Sheridan A, Gage MC
When youre losing weight, especially when engaging in intense weight training or resistance training, your body undergoes physical stress that can weaken the immune system
Oral GLP-1 receptor agonists also present advantages: The small-molecule candidate orforglipron will complete its Phase III trial in 2025 and, if successful, may offer a lower-cost oral alternative to injectable therapies
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
Ideal for men & women with stubborn fat deposits on the chin